Replay available

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

Wed, August 5, 2026 at 8:30 AMendedReplay
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matthew Blackman

Analyst, TD Cowan

Paul Stellato

Interim CFO and VP Controller and Chief Accounting Officer

Larry Beagleson

Analyst, Wells Fargo Securities

David DeMartino

Senior Vice President, Investor Relations

Travis Steed

Analyst, Bank of America Securities

Robbie Marcus

Analyst, J.P. Morgan

Joanne Wunsch

Analyst, Citi

Rick Wise

Analyst, Stifel

Ivan Tornos

Chairman, President and Chief Executive Officer

Patrick Wood

Analyst, UBS

Steve Lichtman

Analyst, William Blair

Vic Chopra

Analyst, BMO Capital Markets

Vijay Kumar

Analyst, Evercore ISI

Matt Taylor

Analyst, Jefferies

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet second quarter 2026 earnings conference call. If anyone needs assistance at any time during the conference, please press the star followed by the zero. As a reminder, this conference is being recorded today, August 5th, 2026. Following today's presentation, there will be a question and answer session. At this time, all participants are needless and only mode. If you have a question, please press the star followed by the one on your push button phone. I would now like to turn the conference over to David DeMartino, Senior Vice President, Investor Relations. Please go ahead. Thank you, operator. Good morning, everyone. Welcome to Zimmerman Biomet's second quarter 2026 earnings conference call. Joining me on today's call are Ivan Tornos, our Chairman, President, and CEO, and Paul Stellato, our Interim CFO and VP Controller and Chief Accounting Officer. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. For a detailed discussion of all these risks and uncertainties, in addition to the inherent limitations of such forward-looking statements, please refer to our SEC filings. Please note we assume no obligation to update these forward-looking statements, even if actual results or future expectations change materially. Additionally, the discussions on this call will include certain non-GAAP financial measures, some of which are forward-looking non-GAAP financial measures. Reconciliation on these measures to the most directly comparable GAAP financial measures and an explanation of our basis for calculat...

More from Zimmer Biomet Holdings, Inc.